.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ORAVIG Drug Profile

« Back to Dashboard
Oravig is a drug marketed by Midatech Pharma Us and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has twenty patent family members in fourteen countries.

The generic ingredient in ORAVIG is miconazole. There are twenty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the miconazole profile page.

Summary for Tradename: ORAVIG

Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: see list1

Pharmacology for Tradename: ORAVIG

Ingredient-typeAzoles
Drug ClassAzole Antifungal

Clinical Trials for: ORAVIG

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Midatech Pharma Us
ORAVIG
miconazole
TABLET;BUCCAL022404-001Apr 16, 2010RXYes6,916,485<disabled>Y <disabled>
Midatech Pharma Us
ORAVIG
miconazole
TABLET;BUCCAL022404-001Apr 16, 2010RXYes7,651,698<disabled> <disabled>
Midatech Pharma Us
ORAVIG
miconazole
TABLET;BUCCAL022404-001Apr 16, 2010RXYes8,518,442<disabled>Y <disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ORAVIG

Country Document Number Estimated Expiration
Portugal1408911<disabled in preview>
China1547464<disabled in preview>
Germany60229456<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc